Infection Digital Registration Assessment Study Guide (2023-2024 Edition)

The 56-Page Infection Digital Registration Assessment Study Guide (2023-2024 Edition) includes:
 
Principles of therapy
Considerations before starting therapy
Notifiable diseases
Sepsis
Amoxicillin
Co-Amoxiclav
Flucloxacillin
Piperacilliin/Tazobactam
Ceftazidime
Cefotaxime
Clarithromycin
Erythromycin
Metronidazole
Doxycycline
Vancomycin
Teicoplanin
Gentamicin
Quinolones
Antituberculosis drugs
Fungal infections
Aspergillosis
Candidiasis
Amphotericin B
Itraconazole
Voriconazole
Ketoconazole
Helminth infection
Malaria prophylaxis
Chloroquine (Avloclor)
Mefloquine (Lariam)
Quinine
Viral Infection
HIV infection
Influenza 
COVID-19
 
The infection study guide is intended to provide high-yield notes in preparation for the GPhC foundation training pharmacy registration assessment. The notes include an overview of the antibiotics, the indications, mechanism of action, dose, side effects, contraindications and important counselling points.
 
Warning signs and therapeutic drug monitoring requirements for high-risk antibiotics are also included.

Disclaimer: These notes are not meant to replace your lecture/study notes but are instead supplementary resources to aid in studying. While all attempts were made to ensure validity and accuracy, there is no guarantee of validity or accuracy. The purchaser of this guide assumes all responsibility for the use of this material. The author does not assume any responsibility or liability whatsoever on behalf of any purchaser or reader of these guides.

No refunds due to the PDF nature of these notes.